Saladax Biomedical Announces Salvatore J. Salamone, Ph.D. Received the Prestigious Dr. C.E. Pippenger Award
Salvatore J. Salamone, Ph.D. received the prestigious Dr. C.E. Pippenger Award at the 2021 International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) annual meeting in Rome, Italy. This award is given to individuals who have made outstanding contributions to the field of Therapeutic Drug Monitoring (TDM). TDM is a field of medical science that seeks to ensure that patients receive a personalized dose of drugs to achieve an optimum therapeutic result. Unfortunately, many medications, such as anticancer, antibiotics, and antifungal treatments, have severe toxicities when overdosed and are ineffective when underdosed. TDM seeks to ensure that the patient receives enough drug to treat the condition but not too much to cause toxicities and potentially death.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210923005035/en/
Dr. Salvatore J. Salamone (Photo: Business Wire)
Dr. Salamone received this award for his contributions to TDM in oncology. He began his work in TDM of anticancer drugs after personally witnessing the adverse reactions caused by toxicity during chemotherapy treatment of family members. He made it his goal that no patient should ever be given anticancer drugs without TDM to ensure proper dosing. He has advocated establishing clinical guidelines for TDM and pharmacology in oncology for over 15 years.
Dr. Salamone accepted this award as a great honor and paid tribute to the influence Dr. Pippenger had on the field of TDM and on him personally. With over 30 years of experience developing diagnostics, Dr. Salamone is recognized globally in the field of drug monitoring and has published extensively in this area. In his acceptance speech, Dr. Salamone spoke about the significant role that TDM plays in personalized medicine.
Dr. Salamone went on to describe that the “unfortunate reality in oncology is that many, if not the majority of, patients are not receiving the correct dose of chemotherapy and we need to act.“ Dr Salamone continued, “Patients are needlessly suffering adverse effects because the dose is too high while others aren't receiving enough drug to treat the cancer effectively. Using the standard body surface area (BSA) dosing method developed in 1916 to administer chemotherapy is now obsolete. Welcome to the 21st century." He described the lack of knowledge of and resistance to TDM by the oncology community. “I urge all IATDMCT members to become more active in engaging the oncology community,” stated Dr Salamone. “Receiving this award inspires me to continue pursuing my goal of making TDM the standard of care in oncology.”
“We will not fully achieve the promise of personalized medicine until every patient receives the correct amount of drug for their body,” said Dr. Salamone. “As the first individual from industry to receive this prestigious award, I am deeply honored and touched that my life’s work has been recognized by such an esteemed organization.”
ABOUT SALADAX BIOMEDICAL, INC.
Headquartered in Bethlehem, PA, Saladax Biomedical, Inc. is a privately held company that develops, manufactures, and markets assays that provide rapid therapeutic drug levels for essential and life-saving medicines prescribed by psychiatrists and oncologists. Since 2007, Saladax's proprietary technology has been used in clinical laboratories or point-of-care settings to assist clinicians monitor and optimize patient care, visit Saladax.com
For more information, visit Saladax.com or MyCareTests.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210923005035/en/
Contact information
Saladax Biomedical, Inc.
Salvatore Salamone, Ph.D., 610-419-6731
ssalamone@saladax.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2026 Future of Fitness Report: Experts from Coherent Solutions Turn Years of Fitness Industry Software Engineering Work Into a Guidebook on Future-proof Digital Transformation in Fitness29.12.2025 19:48:00 EET | Press release
Coherent Solutions has released its 2026 Future of Fitness report, capturing years of domain knowledge from helping emerging and global fitness brands drive digital transformation, innovate, and improve member engagement. “The Future of Fitness: Winning with Digital Value Creation” takes lessons from real projects and fitness enthusiasts, turning them into a guidebook for the next era of fitness. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251229965712/en/ New Fitness Tech Whitepaper by Coherent Solutions While the global fitness market is on track to surpass $257 billion, and brands are expanding globally, pioneering new regions, and implementing new technologies, the report highlights the most effective growth trajectory in acknowledging the importance of technology as equal to supporting the fitness community. "Most people only spend 3–5 hours a week in a gym. That leaves 160+ hours where their choices and habits are i
Hanshow and the University of Cambridge Launch Joint Research on Augmented Intelligent Hybrid Wireless Technology25.12.2025 13:34:00 EET | Press release
Hanshow, a global leader in electronic shelf labels (ESL) and digital store solutions, has entered into a multi-year research collaboration with the University of Cambridge, one of the world’s most prestigious academic institutions. The partnership will focus on joint research and innovation in next-generation intelligent hybrid wireless technologies, marking an important milestone in Hanshow’s continued investment in core technologies and long-term innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251225988816/en/ This collaboration leverages the University of Cambridge’s deep expertise in fundamental wireless technology research, alongside Hanshow’s extensive industry experience, to further strengthen multi-protocol integration capabilities and expand scalable applications across diverse retail scenarios. Guided by shared principles of innovation, collaboration, openness, and knowledge sharing, the two parties aim
Social Development Bank Highlights Strategic Partnerships and Global Initiatives at DeveGo 202524.12.2025 18:27:00 EET | Press release
The Social Development Bank (SDB) hosted the second edition of the Entrepreneurship and Modern Business Practices Forum, “DeveGo 2025”, from 21 to 23 December in Riyadh. Held under the patronage of His Excellency Eng. Ahmed bin Sulaiman Al Rajhi, Minister of Human Resources and Social Development and Chairman of SDB’s Board of Directors, the forum brings together government leaders, global experts, investors, and entrepreneurs to shape the future of entrepreneurship and modern business practices in the Kingdom of Saudi Arabia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251224036724/en/ From right to left: Ahmed Al Rajhi, Saudi's Minister of Human Resources and Social Development, H.E. Rebeca Grynspan, Secretary-General of UNCTAD, and Sultan Al Hamidi, CEO of Social Development (Photo: AETOSWire) Opening the forum, Minister Al Rajhi delivered a keynote speech on the growing vibrancy of Saudi Arabia’s entrepreneurial movem
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 21:51:00 EET | Press release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 19:07:00 EET | Press release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom